The Cameroon Baptist Convention Health Services (CBCHS) has taken a bold step toward transforming patient care by signing a Memorandum of Understanding (MoU) with India’s Maxtar Bio-Genics, a WHO-GMP certified pharmaceutical company. The journey began earlier this year when CBCHS Director of Health Services, Mr. Ngum Samuel, alongside Pharmacist Edward Ngah Ndze, visited India to ensure that any future collaboration would meet the highest standards of quality and safety. This prequalification visit laid the groundwork for a partnership rooted in trust and transparency, designed to strengthen quality control and guarantee consistent access to essential medicines.
This partnership signed by the Director of Health Services and Managing Director of Maxtar Bio-Genics was sealed on June 30, 2026, intended to establish a long-term commercial supply relationship for the manufacture and supply of pharmaceutical products through the CBC Health Services Central Pharmacy, with promises to bridge critical gaps in medication supply and ensure affordable, high-quality medications reach patients across Cameroon.
Meeting the Last Mile of Care
For the CBC Health Services, pharmaceuticals are not just products they are the final bridge between medical expertise and patient well-being. As the Director of Health Services, Mr. Ngum Samuel emphasized, “When we talk of pharmaceuticals, we want to talk more of affordability, accessibility, and quality.” His words reflect a broader vision ensuring that patients receive the medications they need without sacrificing their household income and basic needs. He signaled that this MoU is a move to directly support Cameroon’s national policy on Universal Health Coverage (UHC), a policy goal that seeks to make healthcare both accessible and sustainable. This is a step in ensuring that we want to actually do something that is good for our communities, for ourselves, to the country and for the patients, that we take care of,” he said.
Mr. Jagdish C Bansal, Managing Director for Maxtar Bio-Genetics, reaffirmed Maxtar Bio-Genetics’ commitment to providing the best possible prices on pharmaceutical products, considering the basis of manufacturing costs while strictly adhering to regulatory standards and maintaining uncompromising product quality. He expressed deep gratitude for the partnership and highlighted the privilege of visiting the country, with particular appreciation for the opportunity to tour the Nkwen Baptist Hospital accompanied by the Director of Health Services.
Mr. Rajesh Kumar, Senior Country Manager expressed gratitude to the CBC Director of Health Services and staff for their vote of confidence in Maxtar Bio-Genics, mentioning that this MoU will not only facilitate the consistent supplies, but also facilitate the confidence of the patients in the CBC Health Services in receiving quality healthcare. “Our motto is to provide you the quality product on time or before time,” he affirmed, highlighting the company’s ethical commitment to mass-level healthcare.
Dr Alberic Signang, pharmacist and medical scientist and Pharmacist Edward Ngah Ndze, CBCHS Central Pharmacy General Manager, echoed their optimism for this partnership. Pharmacist Ngah having witnessed the manufacturing plant in India, was convinced of the genuineness and great quality of the medications produced by Maxtar Bio-Genics: a reassurance that strengthens the credibility of this partnership.
The Bigger Picture This collaboration is more than a supply chain agreement; it is a strategic alliance that places patients at the center of healthcare delivery. By facilitating not only the availability but also affordability of these products, CBCHS and Maxtar Bio-Genics are reshaping the healthcare landscape in Cameroon, one prescription at a time.
